COVID-19: regulatory implications for the UK and European life sciences industry
Marie Manley and co-authors from Sidley Austin explain the updates to regulations in the EU and UK in light of the COVID-19 coronavirus pandemic.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
